Synergy for enterococcal endocarditis

Synergy for enterococcal endocarditis refers to the adjunctive therapeutic strategy used in managing infective endocarditis caused by *Enterococcus* species, predominantly *Enterococcus faecalis* and *Enterococcus faecium*

Enterococcal endocarditis is a severe, life-threatening infection of the cardiovascular system characterized by microbial colonization of native or prosthetic heart valves and endocardial tissue, leading to bacterial vegetations, valvular destruction, heart failure, and systemic embolization

Enterococcal endocarditis is a severe, life-threatening infection of the cardiovascular system characterized by microbial colonization of native or prosthetic heart valves and endocardial tissue, leading to bacterial vegetations, valvular destruction, heart failure, and systemic embolization Because enterococci display intrinsic tolerance and low-level resistance to cell-wall active agents and aminoglycosides as monotherapy, they fail to achieve the rapid, reliable bactericidal clearance necessa...

Because enterococci display intrinsic tolerance and low-level resistance to cell-wall active agents and aminoglycosides as monotherapy, they fail to achieve the rapid, reliable bactericidal clearance necessary to sterilize cardiac vegetations Synergistic regimens overcome this tolerance through combination pharmacotherapy—such as pairing a cell-wall synthesis inhibitor with an aminoglycoside to increase drug uptake or combining complementary beta-lactams to achieve differential penicillin-bindin...

Synergistic regimens overcome this tolerance through combination pharmacotherapy—such as pairing a cell-wall synthesis inhibitor with an aminoglycoside to increase drug uptake or combining complementary beta-lactams to achieve differential penicillin-binding protein saturation—thereby restoring potent bactericidal activity